Conversion of Liver Allograft Recipients from Cyclosporine to FK 506-based Immunosuppression: Benefits and Pitfalls

Overview

Journal Transplant Proc

Specialty General Surgery

Date 1991 Feb 1

PMID 1703682

Citations 34

Authors

J J Fung

S Todo

A Tzakis

A Demetris

A Jain

M Alessiani

T E Starzl

Affiliations

Soon will be listed here.

Citing Articles

The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.

Prytula A, Cransberg K, Bouts A, van Schaik R, de Jong H, de Wildt S Clin Pharmacokinet. 2016; 55(9):1129-43.

PMID: 27138785 DOI: 10.1007/s40262-016-0390-7.

Enigmatic pruritus in a kidney transplant patient.

Yates J, Bleyer A, Yosipovitch G, Sangueza O, Murea M Clin Kidney J. 2015; 6(2):194-8.

PMID: 26019849 PMC: 4432448. DOI: 10.1093/ckj/sft009.

Tacrolimus (FK506)-Associated Renal Pathology.

Randhawa P, Starzl T, Demetris A Adv Anat Pathol. 2011; 4(4):265-276.

PMID: 21572890 PMC: 3092646. DOI: 10.1097/00125480-199707000-00032.

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Staatz C, Tett S Clin Pharmacokinet. 2004; 43(10):623-53.

PMID: 15244495 DOI: 10.2165/00003088-200443100-00001.

Single-dose daclizumab induction therapy in patients with liver transplantation.

Yan L, Wang W, Li B, Lu S, Wen T, Lin Q World J Gastroenterol. 2003; 9(8):1881-3.

PMID: 12918145 PMC: 4611568. DOI: 10.3748/wjg.v9.i8.1881.

References

Murase N, Kim D, Todo S, Cramer D, Fung J, Starzl T . Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy. Transplantation. 1990; 50(2):186-9. PMC: 2978534. DOI: 10.1097/00007890-199008000-00002. View

Kahan B . Cyclosporine. N Engl J Med. 1989; 321(25):1725-38. DOI: 10.1056/NEJM198912213212507. View

WIESINGER D, Borel J . Studies on the mechanism of action of cyclosporin A. Immunobiology. 1980; 156(4-5):454-63. DOI: 10.1016/S0171-2985(80)80078-7. View

Fischer G, Bang H . The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. Biochim Biophys Acta. 1985; 828(1):39-42. DOI: 10.1016/0167-4838(85)90006-8. View

Harding M, Handschumacher R, Speicher D . Isolation and amino acid sequence of cyclophilin. J Biol Chem. 1986; 261(18):8547-55. View

Tamura K, Kobayashi M, Hashimoto K, Kojima K, Nagase K, Iwasaki K . A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc. 1987; 19(5 Suppl 6):23-9. View

Starzl T, Fung J . Transplantation. JAMA. 1990; 263(19):2686-7. PMC: 2962591. View

Harding M, Galat A, Uehling D, Schreiber S . A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989; 341(6244):758-60. DOI: 10.1038/341758a0. View

Todo S, Fung J, Starzl T, Tzakis A, Demetris A, Kormos R . Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg. 1990; 212(3):295-305; discussion 306-7. PMC: 1358160. DOI: 10.1097/00000658-199009000-00008. View

10.

Fung J, Todo S, Jain A, McCauley J, Alessiani M, Scotti C . Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc. 1990; 22(1):6-12. PMC: 2903869. View

11.

Francavilla A, Barone M, Starzl T, Zeevi A, Scotti C, Carrieri G . FK 506 as a growth control factor. Transplant Proc. 1990; 22(1):90-2. PMC: 2966015. View

12.

Mazzaferro V, Scotti-Foglieni C, Porter K, Trejo Bellido J, Carrieri G, Todo S . Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc. 1990; 22(1):93-5. PMC: 3005695. View

13.

Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T . FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo). 1987; 40(9):1256-65. DOI: 10.7164/antibiotics.40.1256. View